i-Lumen Scientific is a medical technology company pioneering a new field of treatment in Ophthalmics called "Neural Retinal Therapy"TM, to restore eyesight to patients afflicted with dry age-related macular degeneration (AMD)

​

The Company has developed patent-pending technology which utilises a proprietary, software-based, non-invasive, medical device, developed for the world market. 

This technology utilizes proprietary 

alternating electric field therapy, pioneered 

by company co-founder, Dr. John Jarding, to treat dry AMD. This therapy has been shown 

in our FDA-guided study, to improve and restore vision in 61% of treated patients.

​

Currently, there is no standard of care and no approved treatment, available in the market, to restore or improve eyesight for patients with dry macular degeneration (AMD).